News

Wall Street Trims Ratings for Novo Nordisk Stock, as Ozempic’s Competition Grows
Guggenheim’s Seamus Fernandez cut his rating on Novo Nordisk stock to Hold from Buy on Thursday, as did Evan David Seigerman ...
Futurism on MSN4h
Novo Nordisk Is Getting Absolutely Destroyed
Shares of Novo Nordisk, the Danish pharmaceutical company behind weight-loss drugs Ozempic and Wegovy, plummeted this week.
Eli Lilly Shares Up 13% After Weight Loss Pill Appears As Effective As Ozempic And Mounjaro In Trials
Shares of Eli Lilly soared Thursday morning after the pharmaceutical giant announced a clinical trial of its once-daily ...
Novo Nordisk: A Price Too Low To Ignore
Novo Nordisk's stocks face YTD struggles due to trial results and tariffs, but strong fundamentals and outlook justify a Buy.
BenefitsPRO6h
Eli Lilly’s new GLP-1 weight loss drug, in pill form, would be more affordable than Ozempic
Orforglipron, which could become the first GLP-1 pill — a much more convenient option — is a step closer to hitting the ...
Lilly shares soar on new weight-loss pill that looks to pass Ozempic
Diabetics given the pill called orforglipron lost 16 pounds, or 7.9% of their body weight, over a 40-week period.
Daily Pill May Work as Well as Ozempic for Weight Loss and Blood Sugar
Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable ...
Novo Nordisk to invest $1.09 billion to boost Ozempic, Wegovy production in Brazil
Novo Nordisk , the producer of Ozempic, Wegovy and other medications, will invest 6.4 billion reais ($1.09 billion) in Brazil ...
Novo Nordisk May Lag Behind Eli Lilly In Cardiometabolic Race, Analyst Downgrades Stock
The analyst highlights that Lilly’s drugs, Mounjaro and Zepbound, will likely keep gaining U.S. market share from Novo ...